SCHEMBL25316199

SCHEMBL25316199

Cn1c(N)ncc(-c2ccc3cc(O)ccc3n2)c1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR2 Q92731 3/20 0.44
▸ ESR1 P03372 2/20 0.44
▸ KDM4E B2RXH2 2/20 0.37
▸ FGFR1 P11362 4/20 0.34
▸ SRC P12931 3/20 0.34
▸ EGFR P00533 2/20 0.34
▸ FGFR2 P21802 2/20 0.34
▸ FGFR4 P22455 2/20 0.34
▸ FGFR3 P22607 2/20 0.34
▸ MAPT P10636 2/20 0.33
▸ APP P05067 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ ALOX12 P18054 1/20 0.33
▸ MAPK10 P53779 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ ATM Q13315 1/20 0.33
▸ ABL1 P00519 1/20 0.33
▸ PDGFRB P09619 1/20 0.33
▸ PDGFRA P16234 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25913396 0.86 ESR2 (0.46) ESR2ESR1KDM4EFGFR1SRC
SCHEMBL25913124 0.83 ESR1 (0.43) ESR2ESR1KDM4EFGFR1SRC
SCHEMBL25317161 0.83 ESR1 (0.43) ESR2ESR1KDM4EFGFR1SRC
SCHEMBL25322198 0.83 ESR2 (0.43) ESR2ESR1KDM4EFGFR1SRC
SCHEMBL31010902 0.83 ESR1 (0.43) ESR2ESR1KDM4EFGFR1SRC
SCHEMBL25317946 0.82 ESR1 (0.39) ESR2ESR1KDM4EFGFR1SRC
SCHEMBL25913125 0.80 KCNH2 (0.41) ESR2ESR1KDM4EMAPTMEN1
SCHEMBL25317420 0.80 ESR1 (0.40) ESR2ESR1KDM4EFGFR1SRC
SCHEMBL25317059 0.80 PDGFRB (0.47) ESR2ESR1FGFR1SRCEGFR
SCHEMBL25914664 0.78 ESR1 (0.38) ESR2ESR1FGFR1SRCEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023125812-A1 SUBSTITUTED PYRIMIDONE DERIVATIVE, AND PHARMACEUTICAL COMPOSITION AND MEDICAL USE THEREOF 上海海雁医药科技有限公司 2023-07-06 — — WO disclosed
Send feedback